| Financial Year |
March 31 2023 |
| Monetary Funds |
526,587,907.63 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
26,592,161.10 |
| Accounts Receivable |
417,206,179.88 |
| Advances to Suppliers |
15,682,702.17 |
| Other Receivables |
38,453,603.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
194,493,543.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,627,830.79 |
| Total Current Assets |
1,315,429,280.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
43,913,629.40 |
| Long-term Equity Investment |
168,861,884.83 |
| Investment Properties |
30,147,999.22 |
| Fixed Assetes |
395,495,330.43 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,610,273.55 |
| R&D expenses |
-- |
| Goodwill |
1,324,141,529.84 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
29,402,769.53 |
| Other Non-Current Assets |
14,803,667.61 |
| Sub-Total of Non-Current Assets |
2,123,199,930.85 |
| Total Assets |
3,438,629,211.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,010,125.50 |
| Accounts Payable |
123,060,935.98 |
| Accounts Received In Advance |
80,000.00 |
| Employee Compensation Payable |
20,411,709.04 |
| Taxes Payable |
17,100,543.70 |
| Interest Payable |
-- |
| Dividend Payable |
600,000.00 |
| Other payables |
32,719,533.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,298,174.13 |
| Other Current Liabilities |
11,548,904.67 |
| Sub-Total of Current Liabilities |
325,437,989.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,069,901.07 |
| Total Liabilities |
336,507,890.35 |
| Paid-In Capital(Or Share Stock) |
379,147,970.00 |
| Capital Surplus |
1,652,748,921.95 |
| Surplus Reserve |
172,242,639.42 |
| LESS:Treasury Stock |
25,961,250.00 |
| Undistributed Profits |
923,880,912.88 |
| Minority Stockholder's Interest |
-45,999.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,102,167,320.72 |
| Owner's Equity（Stockholder's Equity） |
3,102,121,321.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,438,629,211.77 |
